Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells

Y Shirazi1, P M Pitha

  • 1Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231.

Virology
|March 1, 1993
PubMed

Insights

Interferon-alpha (IFN-alpha) significantly inhibits human immunodeficiency virus type-1 (HIV-1) replication by blocking provirus formation. This antiviral effect stems from IFN-alpha interfering with the initiation of HIV-1 reverse-transcription.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Interferon-alpha (IFN-alpha) is known to inhibit human immunodeficiency virus type-1 (HIV-1) replication in cell lines.
  • The precise mechanism of IFN-alpha's antiviral activity against HIV-1 requires further elucidation.

Purpose of the Study:

  • To investigate the specific stage at which IFN-alpha inhibits HIV-1 replication.
  • To determine if IFN-alpha affects provirus formation and reverse-transcription.

Main Methods:

  • Polymerase chain reaction (PCR) was used to detect HIV-1 proviral DNA in infected cells.
  • Primers were designed to detect complete or nearly complete proviral DNA and early reverse-transcripts.
  • In vitro assays were performed using cytoplasmic extracts from IFN-alpha-treated cells to assess reverse transcriptase activity.

Main Results:

  • IFN-alpha pretreatment significantly reduced the levels of HIV-1 proviral DNA in infected cells.
  • IFN-alpha was found to interfere with the initiation of HIV-1 reverse-transcription.
  • Cytoplasmic extracts from IFN-alpha-treated cells inhibited HIV-1 reverse transcriptase activity in vitro.

Conclusions:

  • IFN-alpha inhibits HIV-1 replication by blocking provirus formation at the level of reverse-transcription initiation.
  • IFN-alpha demonstrates therapeutic potential for limiting the spread of HIV-1 infection.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...